Parabilis Medicines, Inc. Capital Expenditures
Parabilis Medicines, Inc. (PBLS) reported Capital Expenditures of $985.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- 2026-06-30: Payments to Acquire Property, Plant, and Equipment 6 month $985.00K.
- 2025-06-30: Payments to Acquire Property, Plant, and Equipment 6 month $90.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 6 month |
|---|---|
| 2026-06-30 | $985.00K 10-Q · filed 2026-08-13 |
| 2025-06-30 | $90.00K 10-Q · filed 2026-08-13 |